Skip to main content
SpringerLink
Log in

Stomach Carcinoma Surveillance Counterpoint: Japan

  • Chapter
  • First Online:
Patient Surveillance After Cancer Treatment

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Gastric cancer was overtaken by lung cancer as the leading cause of cancer-related death in Japan in 1999. In 2007, it still accounted for 50,597 deaths (15 % of all deaths from cancer) [1]. The proportion of gastric cancers that are detected early through screening measures is now around 60 % in Japan. These patients require limited surveillance after primary treatment. A large proportion of patients still present with nonresectable tumors at the time of surgery. Those with advanced tumors resected with curative intent are the target of close follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ministry of Health, Labor and Welfare, Japan. Figure for vital statistics in 2007. Available at: (http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei07/hyo7.html) Accessed Jun 2011

  2. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992;33:16–20.

    Article  PubMed  CAS  Google Scholar 

  3. Nobuta A, Asaka M, Sugiyama T, et al. Helicobacter pylori infection in two areas in Japan with different risks for gastric cancer. Aliment Pharmacol Ther. 2004;20 Suppl 1:1–6.

    Article  PubMed  Google Scholar 

  4. Suzuki H, Iwasaki E, Hibi T. Helicobacter pylori and gastric cancer. Gastric Cancer. 2009;12:79–87.

    Article  PubMed  Google Scholar 

  5. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:639–42.

    PubMed  CAS  Google Scholar 

  6. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.

    Article  PubMed  Google Scholar 

  7. The Japanese Gastric Cancer Association (JGCA). The first version of gastric cancer treatment guidelines. Available at: (http://www.jgca.jp/PDFfiles/E-guideline.PDF)

  8. The Japanese Gastric Cancer Association. Guidelines for diagnosis and treatment of carcinoma of the stomach. April 2004 ed. Available at: (http://www.jgca.jp/PDFfiles/Guidelines2004_eng.pdf)

  9. Shimura T, Sasaki M, Kataoka H, et al. Advantages of endoscopic submucosal dissection over conventional endoscopic mucosal resection. J Gastroenterol Hepatol. 2007;22:821–6.

    Article  PubMed  Google Scholar 

  10. Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.

    Article  PubMed  Google Scholar 

  11. Kojima K, Yamada H, Inokuchi M, Hayashi M, Kawano T, Sugihara K. Current status and evaluation of laparoscopic surgery for gastric cancer. Dig Endosc. 2008;20:1–5.

    Article  Google Scholar 

  12. Japan Society for Endoscopic Surgery. A questionnaire survey for endoscopic surgery. The report of the 9th meeting. J Jpn Soc Endosc Surg. 2008;13:525–529.

    Google Scholar 

  13. The Japanese Gastric Cancer Association Registration Committee. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:51–66.

    Article  Google Scholar 

  14. Ikeda Y, Saku M, Kishihara F, Maehara Y. Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg. 2005;92:235–9.

    Article  PubMed  CAS  Google Scholar 

  15. Maehara Y, Tomisaki S, Emi Y, et al. Clinicopathological features of patients who died with second primary cancer after curative resection for gastric cancer. Anticancer Res. 1995;15:1049–54.

    PubMed  CAS  Google Scholar 

  16. Yamamoto M, Yamanaka T, Baba H, et al. Postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinoma. J Surg Oncol. 2008;97:231–5.

    Article  PubMed  Google Scholar 

  17. Sano T, Yamamoto S, Kurokawa Y, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer new eng. J Med. 2008;359:453.

    Google Scholar 

  18. Shirasaka T, Nakano K, Takechi T, et al. Antitumor activity of 1 M tegafur- 0.4 M 5-chloro-2,4-dihydroxy-pyridine- 1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res. 1996;56:2602–6.

    PubMed  CAS  Google Scholar 

  19. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810.

    Article  PubMed  CAS  Google Scholar 

  20. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27–39.

    PubMed  Google Scholar 

  21. Nakajima T, Yamaguchi T (eds). The gastric cancer registry database 1946-2004 (Cancer Institute Hospital gastric cancer database 1946–2004), Tokyo: Kanehara & Co., Ltd; 2006

    Google Scholar 

  22. Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg. 2000;80:353–7.

    Article  Google Scholar 

  23. Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer. 2000;89:255–61.

    Article  PubMed  CAS  Google Scholar 

  24. Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6:142–5.

    Article  PubMed  Google Scholar 

  25. Kim BS, Namkung S, Kim HC, Hwang IK, Hwang WC, Bae SH. CT findings of recurrent gastric carcinoma. Radiol. 2004;11:55–61.

    Google Scholar 

  26. Chen J, Cheong JH, Yun MJ, et al. The role of whole-body positron emission tomography with 18-fluorodeoxyglucose in recurrent gastric cancer. J Clin Oncol. 2004;22(14S):4065.

    Google Scholar 

  27. Cheon SH, Rha SY, Jeung HC, et al. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol. 2008;19:1146–53.

    Article  PubMed  CAS  Google Scholar 

  28. Sakamoto Y, Sano T, Shimada K, et al. Favorable indications for hepatectomy in patients with liver Metastasis from gastric cancer. J Surg Oncol. 2007;95:534–9.

    Article  PubMed  Google Scholar 

  29. Boku N, Yamamoto S, Shirao K, et al. Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912). Japan clinical oncology group trial. Proc Am Soc Clin Oncol. 2007;25:LBA4513 (abst)

    Google Scholar 

  30. Koizumi W, Narahara H, Hara T, et al. S-1plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9(3):215–21.

    Article  PubMed  CAS  Google Scholar 

  31. Kakeji Y, Maehara Y, Sumiyoshi Y, et al. Angiogenesis as a target for gastric cancer. Surgery. 2002;131:S48–54.

    Article  PubMed  Google Scholar 

  32. Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer. 2001;37:918–23.

    Article  PubMed  CAS  Google Scholar 

  33. Niki M, Toyoda M, Nomura E, et al. Expression of transforming growth factor beta (TGF-beta) may contribute, in part, to the variations in histogenesis and the prevalence of peritoneal dissemination in human gastric carcinoma. Gastric Cancer. 2000;3:187–92.

    Article  PubMed  Google Scholar 

  34. Lee HS, Cho SB, Lee HE, et al. Protein expression profiling and molecular classification of gastric cancer by the tissue array method. Clin Cancer Res. 2007;13:4154–63.

    Article  PubMed  CAS  Google Scholar 

  35. The Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd english edition-gastric cancer. 1998;1:10–24

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    Yoshihiro Kakeji MD, PhD, FACS, Masaru Morita & Yoshihiko Maehara

Authors
  1. Yoshihiro Kakeji MD, PhD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaru Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshihiko Maehara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshihiro Kakeji MD, PhD, FACS .

Editor information

Editors and Affiliations

  1. Department of Surgery, Saint Louis University, Vista Avenue 3635, St. Louis, 63110-0050, Missouri, USA

    Frank E. Johnson

  2. Fac. Medicine, Dept. Surgery II, Kyushu University, Fukuoka, 812-8582, Japan

    Yoshihiko Maehara

  3. BC Cancer Agency, West 10th Avenue 600, Vancouver, V5Z 4E6, British Columbia, Canada

    George P. Browman

  4. School of Medicine, Washington University, S. Euclid Ave. 660, St. Louis, 63110, Missouri, USA

    Julie A. Margenthaler

  5. St Helens Teaching Hospital, University of Liverpool, Marshalls Cross Road, St Helens, WA9 3DA, United Kingdom

    Riccardo A. Audisio

  6. Sydney Cancer Centre, Sydney Melanoma Unit, Royal Prince Alfred Hospital, Missenden Road, Camperdown, 2050, New South Wales, Australia

    John F. Thompson

  7. Saint Louis University Medical Center, Saint Louis, 63103, Missouri, USA

    David Y. Johnson

  8. Dana-Farber Cancer Institute, Harvard Medical School, Binney St. 44, Boston, 02115, Massachusetts, USA

    Craig C. Earle

  9. International Atlantic Economic Society, Peachtree Center 299, NEInternatio, Atlanta, 30303, Georgia, USA

    Katherine S. Virgo

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Humana Press

About this chapter

Cite this chapter

Kakeji, Y., Morita, M., Maehara, Y. (2013). Stomach Carcinoma Surveillance Counterpoint: Japan. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-969-7_21

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-968-0

  • Online ISBN: 978-1-60327-969-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation